Antiplatelet Therapy in the Patient with Coronary Stent Undergoing Surgery and Dental Procedure
Antiplatelet drugs are recommended for patients with coronary artery disease, especially if the patient has a coronary stent implantation. Premature discontinuation of antiplatelet drugs either by the patient or medical personnel is the most important risk factor of stent thrombosis which may be complicated by acute myocardial infarction and death. In general, discontinuation of antiplatelet drugs in the patient undergoing dental procedure or some kind of surgery carries a higher risk. Most dental procedures as well as many types of surgery can be performed safely in the patient who continues with antiplatelet therapy..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2011 |
|---|---|
| Erschienen: |
2011 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Journal of Health Science and Medical Research (JHSMR) - 29(2011), 2, Seite 77-87 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Noppadol Chamnarnphol [VerfasserIn] |
|---|
| Links: |
doaj.org [kostenfrei] |
|---|
| Themen: |
Antiplatelet |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
DOAJ009906150 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ009906150 | ||
| 003 | DE-627 | ||
| 005 | 20230503015632.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2011 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)DOAJ009906150 | ||
| 035 | |a (DE-599)DOAJ4bae40f740d34e85ab364add2b7c1fba | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Noppadol Chamnarnphol |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antiplatelet Therapy in the Patient with Coronary Stent Undergoing Surgery and Dental Procedure |
| 264 | 1 | |c 2011 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Antiplatelet drugs are recommended for patients with coronary artery disease, especially if the patient has a coronary stent implantation. Premature discontinuation of antiplatelet drugs either by the patient or medical personnel is the most important risk factor of stent thrombosis which may be complicated by acute myocardial infarction and death. In general, discontinuation of antiplatelet drugs in the patient undergoing dental procedure or some kind of surgery carries a higher risk. Most dental procedures as well as many types of surgery can be performed safely in the patient who continues with antiplatelet therapy. | ||
| 650 | 4 | |a antiplatelet | |
| 650 | 4 | |a aspirin | |
| 650 | 4 | |a clopidogrel | |
| 650 | 4 | |a dental procedure and surgery | |
| 650 | 4 | |a stent | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 773 | 0 | 8 | |i In |t Journal of Health Science and Medical Research (JHSMR) |d Prince of Songkla University, 2020 |g 29(2011), 2, Seite 77-87 |w (DE-627)DOAJ000015954 |x 26300559 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2011 |g number:2 |g pages:77-87 |
| 856 | 4 | 0 | |u https://doaj.org/article/4bae40f740d34e85ab364add2b7c1fba |z kostenfrei |
| 856 | 4 | 0 | |u https://www.jhsmr.org/index.php/jhsmr/article/view/312 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2586-9981 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2630-0559 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2011 |e 2 |h 77-87 | ||